Ocular Pharmacology
Anatomy of Eye
2
Tear Film
3
4
Pharmacodynamics
• It is the biological and therapeutic effect of the
drug (mechanism of action)
• Most drugs act by binding to regulatory
macromolecules, usually neurotransmitters or
hormone receptors or enzymes
• If the drug is working at the receptor level, it can
be agonist or antagonist
• If the drug is working at the enzyme level, it can be
activator or inhibitor
5
Pharmacokinetics
• It is the absorption, distribution, metabolism, and
excretion of the drug
• A drug can be delivered to ocular tissue as:
• Locally:
• Eye drop
• Ointment
• Periocular injection
• Intraocular injection
• Systemically:
• Orally
• IV
6
Pharmacokinetics of Ocular Drugs
Ø Classical pharmacokinetic theory based on
systemically administered drugs does not fully
apply to all ophthalmic drugs
Ø Topical route – most commonly used
7
Absorption
Rate & extent of absorption of topically instilled drugs
depends upon –
1. Time
“Drug the druginto
penetration remains in the
the eye cul-de-sac &
is approximately
precorneal
linearly related tear
to itsfilm
concentration in the tear film.”
2. Elimination by nasolacrimal drainage
3. Drug binding to tear proteins
4. Drug metabolism by tear & tissue proteins
5. Diffusion across cornea & conjunctiva
8
Distribution
Transcorneal absorption
Accumulation in aqueous humor
Distribution to intraocular structures
Trabecular meshwork pathway
Distribution to systemic
9 circulation
Distribution
Ø Melanin binding of certain drugs –
- Eg:
1. Mydriatic effect of alpha adrenergic agonists slower in onset -
darkly pigmented irides compared to those with lightly
pigmented irides
2. Atropine’s mydriatic effect – long lasting in non-albino rabbits
than in albino rabbits
3. Accumulation of chloroquine in retinal pigment epithelium –
Bull’s eye maculopathy
10
Metabolism
Ø Enzymatic biotransformation of ocular
drugs- significant
Ø Esterases – particular interest
Eg: Development of prodrugs for enhanced
ocular permeability
1. Dipivefrin hydrochloride
2. Latanoprost
11
12
Drug Delivery in Eyes
Topical Periocular Intraocular Systemic
drop Subconjunctival Intracameral Oral
ointment Subtenon Intravitreal intravenous
gel Peribulbar Intramuscular
Soft contact lens Retrobulbar
Ocular Routes of Drug Administration
Sr.N Route Special Utility Limitations &
o Precautions
1. Topical --Convenient --Compliance
-- Economical --Corneal & conjunctival
--Relatively safe toxicity
--Nasal mucosal toxicity
--Systemic side effects from
nasolacrimal absorption
2. Subconjunctival, -Anterior segment -Local Toxicity
sub-Tenon’s & infections -Globe perforation
Retrobulbar -Posterior uveitis -Optic nerve trauma
injections -Cystoid Macular -Central retinal artery or
Edema (CME) vein occlusion
3. Intraocular Anterior segment -Corneal toxicity
Injections surgery or infections -Relatively short duration of
action
4. Intravitreal Immediate local effect Retinal toxicity
14
Injection
Factors influencing local drug penetration into ocular tissue
• Drug concentration and solubility:
higher concentration -- better penetration
e.g pilocarpine 1-4% but limited by reflex tearing
• Viscosity: addition of methylcellulose and polyvinyl
alcohol increases drug penetration by increasing
contact time with cornea and altering corneal
epithelium
• Lipid solubility: higher lipid solubility- more
penetration
15
Factors influencing local drug penetration into ocular tissue
• Surfactants: preservatives alter cell membrane in
cornea and increase drug permeability e.g.
benzylkonium and thiomersal
• pH: the normal tear pH is 7.4
If drug pH is much different, this will cause reflex
tearing
• Drug tonicity: when an alkaloid drug is put in relatively
alkaloid medium, the proportion of the uncharged
form will increase, thus more penetration
• Molecular weight and size
16
TOPICAL
Drop (Gutta)- simplest and most convenient, mainly for day time use
1 drop=50 microlitre
Conjuctival sac capacity=7-13 micro liter
so, even 1 drop is more than enough
Method: hold the skin below the lower eye lid
pull it forward slightly
INSTILL 1 drop
• measures to increase drop absorption:
-wait 5-10 minutes between drops
-compress lacrimal sac
17
-keep lids closed for 5 minutes after instillation
Ointments
• Increase the contact time of ocular medication to ocular
surface, thus better effect
• It has the disadvantage of
blurring vision
• The drug has to be highly lipid soluble with some water
solubility to have maximum effect as ointment
18
Peri-ocular injections
• They reach behind iris-
lens diaphragm better
t h a n t o p i c a l
application
• E.g. subconjunctival,
subtenon, peribulbar,
or retrobulbar
• This route bypass the
conjunctival and
corneal epithelium
which is good for
drugs with low lipid
solubility (e.g.
penicillins) 19
Periocular
Subconjunctival - To achieve higher concentration
Drugs which cannot penetrate cornea due to large size
Penetrate via sclera
Subtenon—Ant. Subtenon– diseases anterior to the lens
Post. Subtenon– disease posterior to the lens
Retrobulbar- Optic neuritis
Papillitis
Posterior uveitis
Anesthesia 20
Intraocular injections
• Intracameral or intravitreal
• E.g.
• Intracameral
acetylcholine (miochol)
during cataract surgery
• Intravitreal antibiotics in
cases of
endophthalmitis
• Intravitreal steroids in
macular edema
• Intravitreal Anti-VEGF
for DR
21
Sustained-release devices
• These are devices that
deliver an adequate
supply of medication
at a steady-state level
• E.g.
• Ocusert delivering
pilocarpine
• Timoptic XE
delivering timolol
• Ganciclovir
sustained-release
intraocular device
• Collagen shields 22
Systemic drugs
• Oral or IV
• Factor influencing systemic drug
penetration into ocular tissue:
• lipid solubility of the drug: more
penetration with high lipid solubility
• Protein binding: more effect with low
protein binding
• Ocular inflammation: more
penetration with ocular inflammation
23
Therapeutic applications of
Drugs in Ophthalmology
24
Common ocular drugs
• Antibacterials (antibiotics)
• Antivirals
• Antifungals
• Mydriatics and cycloplegics
• Antiglaucoma medications
Corticosteroids
• Anti-inflammatory agents
NSAID’s
• Ocular Lubricants
• Local anesthetics
• Ocular diagnostic drugs
• Ocular Toxicology 25
Topical Antibacterial Agents Commercially
Available for Ophthalmic Use
Azithromycin 1% solution H Conjunctivitis
Ciprofloxacin 0.3% solution; H -Conjunctivitis
hydrochloride 0.3% ointment D-RCD -Keratitis
-Keratoconjunctivitis
-Corneal Ulcers
-Blepharitis
-Dacryocystitis
Erythromycin 0.5% ointment H -Superficial Ocular Infections
involving cornea or conjunctiva
Gatifloxacin 0.3% solution H Conjunctivitis
H- Hypersensitivity ; D-RCD – Drug Related Corneal Deposits
26
Topical Antibacterial Agents Commercially
Available for Ophthalmic Use
Gentamicin 0.3% H Conjunctivitis, Keratitis
sulfate solution
Levofloxacin 0.5% H Conjunctivitis
Levofloxacin 1.5% H Corneal Ulcers
Moxifloxacin 0.5% H Conjunctivitis
solution
Ofloxacin 0.3% H Conjunctivitis
solution Corneal Ulcers
Tobramycin 0.3% H External infections of the eye
sulfate solution
0.3% 27
ointment
Antibacterials (antibiotics)
• Penicillins
• Cephalosporins
• Sulfonamides
• Tetracyclines
• Chloramphenicol
• Aminoglycosides
• Fluoroquinolones
• Vancomycin
• Macrolides
28
Antibiotics
• Used topically in prophylaxis
(pre and postoperatively) and
treatment of ocular bacterial
infections.
• Used orally for the treatment
of preseptal cellulitis
e.g. amoxycillin with
clavulanate, cefaclor
• Used intravenously for the
treatment of orbital cellulitis
e.g. gentamicin, cephalosporin,
vancomycin,
• Can be injected intravitrally for
the treatment of 29
endophthalmitis
• Specific antibiotic for almost each organisms
• Sulfonamides- Chlamydial infections like TRACHOMA
INCLUSION CONJUNCTIVITIS
TOXOPLAMOSIS
Bacterial cell wall synthesis inhibitors-
Penicillin
Cephalosporins
I) First generation- Gram + cocci eg cephazoline
ii) Second generation —Gram – ve and antistaphylococcal—
cefuroxime
30
iii) Third generation– Gram –ve bacilli --ceftriaxones
• Side effects- allergic reaction
neutropenia
thrombocytopenia
Amino glycosides
Mainly against gram negative bacilli
Bacterial protein synthesis inhibitors
Gentamycin- 0.3% eye drops
Tobramycin- 0.3% eye drop
Neomycin— 0.3-0.5% eye drops
Amikacin ----- 1% eye drops 31
Tetracycline
Inhibit protein synthesis
active against both gram+ and gram -ve, some
fungi and Chlamydia
Chloramphenicol
Broad spectrum ,bacteriostatic,
gram+/gram-ve, Chlamydia
0.5% Eye drops, ointment 32
Fluoroqinolones
• Most frequently used topical broad spectrum
antibiotics
• Ciprofloxacin – 0.3% eye drops
• Ofloxacin - 0.3% eye drops
• Moxifloxacin - 0.5 % eye drops
• Levofloxacin and Besifloxacin eye drops
33
Antibiotics
• Trachoma can be treated by
topical and systemic
tetracycline or erythromycin,
or systemic azithromycin.
• Bacterial keratitis
(bacterial corneal ulcers)
can be treated by topical
fortified cephalosporins,
aminoglycosides,
vancomycin, or
fluoroquinolones.
• Bacterial conjunctivitis is
usually self limited but topical
erythromycin,
aminoglycosides,
fluoroquinolones, or
chloramphenicol can be used
34
Dacryocystitis - Infection of
the lacrimal sac
35
Hordeolum/ Stye – Infection of the meibomian, Zeis
or Moll gland
36
Conjunctivitis – Inflammatory
process of the conjunctiva
37
Blepharitis – Bilateral inflammatory process
of the eyelids
38
Antiviral Agents for
Ophthalmic Use
Trifluridine Topical (1% solution) PK, H -Herpes simplex keratitis
- Keratoconjuctivitis
Acyclovir Oral (200 mg -Herpes zoster
capsules, 800 mg ophthalmicus
tablets) - Herpes simplex
Intravenous iridocyclitis
Valacyclovir Oral (500- & 1000 -Herpes simplex keratitis
mg) -Herpes zoster
ophthalmicus
Famciclovir Oral (125-,250 mg -Herpes simplex keratitis
tablets) -Herpes zoster
ophthalmicus
39
PK – Punctate Keratopathy ; H - Hypersensitivity
Antiviral Agents for
Ophthalmic Use…
Foscarnet Intravenous ----- Cytomegalovirus
Intravitreal Retinitis
Ganciclovir Intravenous, Oral ----- Cytomegalovirus
Intravitreal implant Retinitis
Valganciclovir Oral ------- Cytomegalovirus
Retinitis
Cidofovir Intravenous ------ Cytomegalovirus
Retinitis
40
Antivirals
• Acyclovir- Most commonly used anti-viral
3% ointment 5 times-10-14 days
800mg oral 5 times 10-14 days
Intravenous for Herpes zoster retinitis
Others
INDICATIONS
Idoxuridine HZ keratitis
Viral uveitis
Vidarabine
Cytarabine 41
VIRAL DENTRITIC ULCER
42
CMV Retinitis
43
Antifungal Agents for Ophthalmic Use
Amphotericin B 0.1-0.5% solution Yeast & fungal keratitis &
endophthalmitis
0.8-1 mg Subconjunctival - Yeast & fungal endophthalmitis
5 microgram intravitreal - Yeast & fungal endophthalmitis
injection - Yeast & fungal endophthalmitis
Natamycin 5% topical suspension -Yeast & fungal blepharitis
-Conjunctivitis ; keratitis
Fluconazole Topical, Oral & Intravenous Yeast keratitis & endophthalmitis
Itraconazole Topical ,Oral Yeast & fungal keratitis &
endophthalmitis
Ketoconazole Oral Yeast keratitis & endophthalmitis
Miconazole 1% topical solution 44 Yeast & fungal keratitis
ANTIFUNGAL
INDICATIONS
Fungal corneal ulcer
Fungal retinitis/ Endophthalmitis
Commonly used drugs are
• Polyenes
• damage cell membrane of susceptible fungi
• e.g. amphotericin B, natamycin, nystatin
• side effect: nephrotoxicity
• Imidazoles
• increase fungal cell membrane permeability
• e.g. miconazole, ketoconazole,fluconazole
• Flucytocine
• act by inhibiting DNA synthesis 45
46
Mydriatics and cycloplegics
• Dilate the pupil, ciliary muscle paralysis
• CLASSIFICATION
Short acting- Tropicamide (4-6 hours)
Intermediate- homatropine ( 24 hours)
Long acting- atropine (2 weeks)
Indications
corneal ulcer
uveitis
47
cycloplegic refraction
1 Atropine 0.5%, 1% & 2% -Cycloplegia -Photosensitivity
solution; 1% -Mydriasis -Blurred vision
ointment -Cycloplegic
retinoscopy
-Dilated
fundoscopic Exam
2 Scopolamine 0.25% solution Cycloplegia Photosensitivity
-Mydriasis -Blurred vision
3 Homatropine 2% & 5% Cycloplegia Photosensitivity
solution -Mydriasis -Blurred vision
4 Cyclopentolate 0.5% 1% solution Cycloplegia Photosensitivity
-Mydriasis -Blurred vision
5 Tropicamide 0.5% & 1% Cycloplegia Photosensitivity
solution -Mydriasis -Blurred vision
48
Obat Anti Glaukoma
OBAT
BERPENGARUH
PADA
PENGLIHATAN
Acne Isotretinoin dry eyes and a sudden decrease
Medication in night vision
Antihistamines CTM Narrow angle glaucoma
!sudden vision changes,
headache pain around the eyes,
blurred vision, or double vision
Antimalaria chloroquine retinal toxicity, leading to
permanent vision loss
Corticosteroid prednison cataract or glaucoma
Erectile sildenafil blurred vision, sensitivity to
Dysfunction light, and seeing a temporary
Drugs
blue tinge
Ethambutol visual acuity, or clarity, and
difficulty seeing certain colors
Phenothiazines chlorpromazine sensitivity to light, changes
in color vision, blurred
vision, and problems seeing
at night
Tamoxifen crystalline retinopathy,
include blurred vision,
corneal changes, and an
increased risk for cataracts
Topiramate Narrow angle glaucoma
!sudden vision changes,
headache pain around the
eyes, blurred vision, or
double vision
PUPIL
Ukuran pupil
dipengaruhi:
– Cahaya
– Parasimpatis
– Simpatis
MIDRIASIS MIOSIS
• Cahaya redup++ • Cahaya terang++
• Parasimpatomimetik++
• Anti-muskarinik++
• Muskarinik agonis++
• Simpatomimetik+
• Stimulasi reseptor
• Alfa1-adrenoseptor opioid++
agonis+ • Alfa1-adrenoseptor
antagonis+
CATATAN:
• Obat tetes mata dapat sebabkan efek samping sistemik
• Pigmen iris dapat menyerap obat (mis. Atropin)
• Hitam > coklat > hijau > abu-abu > biru
• Onset lambat, durasi memanjang
• Beberapa obat dapat merubah warna mata
• Epinefrin, latanoprost
• Zat pengawet / tambahan pada tetes mata dapat
sebabkan alergi
EFEK SAMPING
ETAMBUTOL
1. neuritis retrobular
" Buta warna merah-hijau (etambutol 25 mg/kg selama
beberapa bulan) ! Reversibel
"penurunan ketajaman penglihatan
2. Otto-toksisitas (jarang), nervedeafness (biasanya
irreversible) pada terapi klorokuin dosis tinggi jangka
panjang
Tinitus dan berkurangnya pendengaran "500 mg
klorokuin 1x seminggu dalam beberapa bulan
EFEK SAMPING
KLOROKUIN
• Kerusakan retina yang ireversibel, penglihatan
kabur, kesulitan untuk memfokuskan pandangan dan
penglihatan berkabut.
• Gangguan penglihatan parah bisa terjadi jika
klorokuin digunakan jangka panjang dengan dosis
lebih dari 150 mg perhari
• Pengobatan jangka panjang dengan dosis tinggi
menyebabkan: keratopathy, transient edema
Thank you
74